Cargando…

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain

BACKGROUND: Clinical trials have not yet compared the efficacy of capsaicin 8% patch with current standard therapy in peripheral neuropathic pain (PNP). OBJECTIVES: Head‐to‐head efficacy and safety trial comparing the capsaicin patch with pregabalin in PNP. METHODS: Open‐label, randomized, multicent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haanpää, M., Cruccu, G., Nurmikko, T.J., McBride, W.T., Docu Axelarad, A., Bosilkov, A., Chambers, C., Ernault, E., Abdulahad, A.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738436/ https://www.ncbi.nlm.nih.gov/pubmed/26581442 http://dx.doi.org/10.1002/ejp.731

Ejemplares similares

Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain
por: Cruccu, G., et al.
Publicado: (2017)

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland
por: Mankowski, Colette, et al.
Publicado: (2016)

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
por: Huygen, Frank, et al.
Publicado: (2020)

Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
por: Mankowski, Colette, et al.
Publicado: (2017)

Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: A multicentre, randomized, assessor-blinded study
por: Jensen, TS, et al.
Publicado: (2014)

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
por: Peppin, John F, et al.
Publicado: (2011)

Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain
por: Giaccari, Luca Gregorio, et al.
Publicado: (2021)

Peripheral Neuropathic Pain Following Breast Cancer: Effectiveness and Tolerability of High-Concentration Capsaicin Patch
por: Dupoiron, Denis, et al.
Publicado: (2022)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014)

EHMTI-0328. Comparative evaluation of pregabalin, gabapentin, carbamazepine and topiramat in migraine
por: Axelerad, A Docu, et al.
Publicado: (2014)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis
por: Wagner, Till, et al.
Publicado: (2013)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012)

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
por: Freynhagen, Rainer, et al.
Publicado: (2015)

Retraction: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2014)

Pain‐relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice
por: Hansson, P., et al.
Publicado: (2018)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability
por: Laklouk, Muhammad, et al.
Publicado: (2016)

A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
por: Srivastava, A., et al.
Publicado: (2012)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials
por: Freeman, Roy, et al.
Publicado: (2015)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications
por: Freynhagen, Rainer, et al.
Publicado: (2021)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain
por: Webster, Lynn R, et al.
Publicado: (2012)

Topical Capsaicin for the Treatment of Sensory Neuropathic Cough
por: Hoesli, Rebecca C., et al.
Publicado: (2021)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study
por: Maihöfner, CG, et al.
Publicado: (2014)

The Effects of Pregabalin and the Glial Attenuator Minocycline on the Response to Intradermal Capsaicin in Patients with Unilateral Sciatica
por: Sumracki, Nicole M., et al.
Publicado: (2012)

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups
por: Martini, Christian, et al.
Publicado: (2012)

Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007)

Pregabalin in post traumatic neuropathic pain: Case studies
por: Singh, Rakesh Kumar, et al.
Publicado: (2012)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in Non-diabetic patients
por: Giménez-Milà, Marc, et al.
Publicado: (2014)

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
por: Sicras‐Mainar, Antoni, et al.
Publicado: (2016)

A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain
por: Shah, Islam, et al.
Publicado: (2022)

Vaccination Granuloma Itch Treated with Capsaicin 8% Patches
por: HOFFMANN, Stine, et al.
Publicado: (2020)

High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience
por: Filipczak-Bryniarska, Iwona, et al.
Publicado: (2017)

Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
por: Laude-Pagniez, Eulalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_68019n72nacbrueijq81k3d97o